nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium Tetradecyl Sulfate—Seasonal allergy—Mometasone—systemic scleroderma	0.0897	0.178	CcSEcCtD
Sodium Tetradecyl Sulfate—Rhinitis seasonal—Mometasone—systemic scleroderma	0.0861	0.171	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Beta2 integrin cell surface interactions—TGFBI—systemic scleroderma	0.0684	0.157	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.0496	0.114	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.0292	0.0671	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—SELP—systemic scleroderma	0.0244	0.0559	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.0232	0.0533	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.0232	0.0533	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Necrosis—Captopril—systemic scleroderma	0.021	0.0419	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—digestive system—systemic scleroderma	0.0209	0.336	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.0205	0.0472	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Ulcer—Mometasone—systemic scleroderma	0.0199	0.0395	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.0186	0.0426	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Ulcer—Captopril—systemic scleroderma	0.0174	0.0347	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.0164	0.0377	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Ulcer—Leflunomide—systemic scleroderma	0.0144	0.0286	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—connective tissue—systemic scleroderma	0.0137	0.22	CbGeAlD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Lisinopril—systemic scleroderma	0.0117	0.0233	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.0108	0.0248	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Mycophenolate mofetil—systemic scleroderma	0.0102	0.0204	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.0101	0.0232	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—digestive system—systemic scleroderma	0.0099	0.159	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—tendon—systemic scleroderma	0.00942	0.152	CbGeAlD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.0093	0.0214	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.00919	0.0211	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Necrosis—Prednisone—systemic scleroderma	0.00884	0.0176	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—lung—systemic scleroderma	0.00827	0.133	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.00823	0.0189	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00777	0.0155	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Methotrexate—systemic scleroderma	0.00739	0.0147	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Prednisone—systemic scleroderma	0.00734	0.0146	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Mometasone—systemic scleroderma	0.0067	0.0133	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Methotrexate—systemic scleroderma	0.00665	0.0132	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—SELP—systemic scleroderma	0.00629	0.0145	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Urticaria—Pentoxifylline—systemic scleroderma	0.00617	0.0123	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Methotrexate—systemic scleroderma	0.00613	0.0122	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Captopril—systemic scleroderma	0.00589	0.0117	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—RHOB—systemic scleroderma	0.00588	0.0135	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Methotrexate—systemic scleroderma	0.0058	0.0115	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Mometasone—systemic scleroderma	0.00573	0.0114	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00572	0.0114	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—SELP—systemic scleroderma	0.00557	0.0128	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—CSK—systemic scleroderma	0.00535	0.0123	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—RHOB—systemic scleroderma	0.0052	0.0119	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—ITGAM—systemic scleroderma	0.00503	0.0116	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Pentoxifylline—systemic scleroderma	0.00494	0.00983	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Pentoxifylline—systemic scleroderma	0.00487	0.00969	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00485	0.00966	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—CSK—systemic scleroderma	0.00474	0.0109	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—TGFB1—systemic scleroderma	0.00468	0.0107	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Pentoxifylline—systemic scleroderma	0.00461	0.00919	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.00446	0.0102	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—ITGAM—systemic scleroderma	0.00445	0.0102	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Mometasone—systemic scleroderma	0.00426	0.00848	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Mometasone—systemic scleroderma	0.0042	0.00836	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00417	0.0083	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Leflunomide—systemic scleroderma	0.00415	0.00826	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—ITGAM—systemic scleroderma	0.00401	0.0092	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—CD247—systemic scleroderma	0.00401	0.0092	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Mometasone—systemic scleroderma	0.00398	0.00793	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Mycophenolic acid—systemic scleroderma	0.00396	0.00788	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Leflunomide—systemic scleroderma	0.00385	0.00767	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Azathioprine—systemic scleroderma	0.00379	0.00754	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—TNFAIP3—systemic scleroderma	0.00375	0.00862	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Captopril—systemic scleroderma	0.00374	0.00745	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Captopril—systemic scleroderma	0.00369	0.00734	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00365	0.00727	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Leflunomide—systemic scleroderma	0.00358	0.00712	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Lisinopril—systemic scleroderma	0.00357	0.0071	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Captopril—systemic scleroderma	0.0035	0.00696	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Lisinopril—systemic scleroderma	0.00331	0.00659	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Azathioprine—systemic scleroderma	0.00327	0.0065	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Azathioprine—systemic scleroderma	0.00322	0.00641	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Mycophenolate mofetil—systemic scleroderma	0.00312	0.00622	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—ACE—systemic scleroderma	0.00309	0.00709	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Leflunomide—systemic scleroderma	0.00309	0.00614	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Lisinopril—systemic scleroderma	0.00307	0.00612	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Azathioprine—systemic scleroderma	0.00305	0.00608	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Leflunomide—systemic scleroderma	0.00304	0.00605	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00294	0.00586	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0029	0.00578	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Mycophenolic acid—systemic scleroderma	0.0029	0.00577	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Leflunomide—systemic scleroderma	0.00288	0.00574	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Mycophenolic acid—systemic scleroderma	0.00275	0.00547	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—ACE—systemic scleroderma	0.00273	0.00628	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00269	0.00536	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Lisinopril—systemic scleroderma	0.00265	0.00528	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Lisinopril—systemic scleroderma	0.00261	0.0052	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—MMP1—systemic scleroderma	0.00252	0.00579	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CSK—systemic scleroderma	0.00248	0.0057	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Lisinopril—systemic scleroderma	0.00248	0.00493	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Prednisone—systemic scleroderma	0.00248	0.00493	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IRF5—systemic scleroderma	0.00244	0.00561	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IRF8—systemic scleroderma	0.00233	0.00536	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—ITGAM—systemic scleroderma	0.00233	0.00536	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CD247—systemic scleroderma	0.00233	0.00536	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00232	0.00462	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00456	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—MMP1—systemic scleroderma	0.00223	0.00512	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—TNFAIP3—systemic scleroderma	0.00219	0.00502	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00432	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Immune System—BLK—systemic scleroderma	0.00216	0.00496	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.00208	0.00476	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00207	0.00412	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MMP1—systemic scleroderma	0.00198	0.00455	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Urticaria—Prednisone—systemic scleroderma	0.00197	0.00392	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—NOS3—systemic scleroderma	0.00183	0.0042	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Prednisone—systemic scleroderma	0.00182	0.00363	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Methotrexate—systemic scleroderma	0.00177	0.00352	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CTLA4—systemic scleroderma	0.00177	0.00406	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MMP1—systemic scleroderma	0.00176	0.00403	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Urticaria—Methotrexate—systemic scleroderma	0.00164	0.00327	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—NOS3—systemic scleroderma	0.00162	0.00371	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—CCL2—systemic scleroderma	0.00161	0.0037	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Prednisone—systemic scleroderma	0.00157	0.00313	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Prednisone—systemic scleroderma	0.00155	0.00309	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MMP2—systemic scleroderma	0.00153	0.00352	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Methotrexate—systemic scleroderma	0.00152	0.00304	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Prednisone—systemic scleroderma	0.00147	0.00293	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Immune System—HLA-DQB1—systemic scleroderma	0.00146	0.00335	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—CCL2—systemic scleroderma	0.00143	0.00328	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL1A—systemic scleroderma	0.00138	0.00318	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CD40LG—systemic scleroderma	0.00138	0.00316	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MMP2—systemic scleroderma	0.00136	0.00312	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Methotrexate—systemic scleroderma	0.00132	0.00262	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Methotrexate—systemic scleroderma	0.0013	0.00258	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Methotrexate—systemic scleroderma	0.00123	0.00245	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—TGFB1—systemic scleroderma	0.00121	0.00278	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—TGFB1—systemic scleroderma	0.00107	0.00246	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL1B—systemic scleroderma	0.000722	0.00166	CbGpPWpGaD
